Developing a new treatment for safety evaluation and clinical trials.
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL
This study is working on a new medicine called NCGC00413972 to make sure it’s safe and effective for people, with the hope that it could offer new treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-11140931 on NIH RePORTER |
What this research studies
This research focuses on the development of a new compound, NCGC00413972, which involves its chemistry, manufacturing, and controls (CMC) to ensure it is safe for preclinical evaluation and future clinical trials. The project aims to establish rigorous standards and processes for the compound's production and testing, which is crucial for determining its safety and efficacy in humans. Patients may benefit from this research as it could lead to new treatment options based on the findings from the clinical trials that follow.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals with conditions that NCGC00413972 aims to address, pending successful preclinical and clinical evaluations.
Not a fit: Patients who do not have the specific conditions targeted by NCGC00413972 may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a new treatment that improves patient outcomes.
How similar studies have performed: While this approach is common in drug development, the specific compound NCGC00413972 is novel and has not been tested in clinical trials yet.
Where this research is happening
Albany, United States
- Albany Molecular Research, INC. — Albany, United States (Active)
Researchers
- Principal investigator: Penny, Brian — Albany Molecular Research, INC.
- Study coordinator: Penny, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.